SCHEMBL14533573

SCHEMBL14533573

Nc1ccccc1-c1cc2ccccc2c(Cl)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.40
HSD17B10 Q99714 4/20 0.40
L3MBTL1 Q9Y468 4/20 0.40
KDM4E B2RXH2 4/20 0.40
NPC1 O15118 3/20 0.40
GAA P10253 3/20 0.40
HSP90AA1 P07900 2/20 0.40
HSP90AB1 P08238 2/20 0.40
ADORA2A P29274 1/20 0.40
HPGD P15428 3/20 0.39
TSHR P16473 2/20 0.39
CYP3A4 P08684 1/20 0.39
KEAP1 Q14145 1/20 0.39
IDO1 P14902 1/20 0.39
MAPK1 P28482 1/20 0.38
CASP1 P29466 1/20 0.38
HIF1A Q16665 1/20 0.38
RAB9A P51151 2/20 0.37
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13316853 0.79 CYP1A2 (0.40) ALDH1A1HSD17B10L3MBTL1KDM4ENPC1
SCHEMBL786476 0.76 ACP1 (0.51) CYP3A4
SCHEMBL4773825 0.76 HSP90AA1 (0.56) ALDH1A1HSD17B10KDM4EGAAHSP90AA1
SCHEMBL31388225 0.74 MEN1 (0.55) ALDH1A1L3MBTL1KDM4EHSP90AA1HSP90AB1
SCHEMBL786133 0.74 MEN1 (0.55) ALDH1A1L3MBTL1KDM4EHSP90AA1HSP90AB1
SCHEMBL13804169 0.74 PDPK1 (0.43) ALDH1A1HSD17B10L3MBTL1KDM4EGAA
SCHEMBL509219 0.72 HSP90AA1 (0.56) ALDH1A1HSD17B10KDM4EGAAHSP90AA1
SCHEMBL4766383 0.71 ADORA2A (0.46) ALDH1A1HSD17B10KDM4ENPC1HSP90AA1
SCHEMBL4769077 0.71 MEN1 (0.44) ALDH1A1L3MBTL1KDM4EGAAHSP90AA1
SCHEMBL22201436 0.70 PRKCH (0.52) ALDH1A1L3MBTL1KDM4ENPC1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070099873-A1 Quinolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED 2007-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070099873-A1 Quinolines useful as modulators of ion channels KCNQ1, KCNQ2, KCNQ5 ALDH1A1 2630/4885HSD17B10 3135/4885L3MBTL1 4089/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.